Literature DB >> 20338187

The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells.

Ying-Chun Chen1, Jong-Kai Hsiao, Hon-Man Liu, I-Yin Lai, Ming Yao, Szu-Chun Hsu, Bor-Sheng Ko, Yao-Chang Chen, Chung-Shi Yang, Dong-Ming Huang.   

Abstract

Superparamagnetic iron oxide (SPIO) nanoparticles are very useful for monitoring cell trafficking in vivo and distinguish whether cellular regeneration originated from an exogenous cell source, which is a key issue for developing successful stem cell therapies. However, the impact of SPIO labeling on stem cell behavior remains uncertain. Here, we show the inhibitory effect of Ferucarbotran, an ionic SPIO, on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Ferucarbotran caused a dose-dependent inhibition of osteogenic differentiation, abolished the differentiation at high concentration, promoted cell migration, and activated the signaling molecules, beta-catenin, a cancer/testis antigen, SSX, and matrix metalloproteinase 2 (MMP2). An iron chelator, desferrioxamine, suppressed all the above Ferucarbotran-induced actions, demonstrating an important role of free iron in the inhibition of osteogenic differentiation that is mediated by the promotion of cell mobilization, involving the activation of a specific signaling pathway. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338187     DOI: 10.1016/j.taap.2010.03.011

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  53 in total

1.  Experimental study of super paramagnetic iron oxide labeled synovial mesenchymal stem cells.

Authors:  Fang-Yuan Yu; Hong-Hang Li; Chang-Hui Chen; Sheng-Rong Bi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.

Authors:  In K Cho; Silun Wang; Hui Mao; Anthony Ws Chan
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

Review 3.  Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy.

Authors:  Yingli Fu; Dara L Kraitchman
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

Review 4.  The application of super paramagnetic iron oxide-labeled mesenchymal stem cells in cell-based therapy.

Authors:  Yiying Qi; Gang Feng; Zhongming Huang; Weiqi Yan
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

5.  Impacts of fluorescent superparamagnetic iron oxide (SPIO)-labeled materials on biological characteristics and osteogenesis of bone marrow mesenchymal stem cells (BMSCs).

Authors:  Guangping Zhang; Zhenwen Na; Bin Ren; Xin Zhao; Weixian Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Superparamagnetic iron oxide promotes osteogenic differentiation of rat adipose-derived stem cells.

Authors:  Hai-Tao Xiao; Lei Wang; Bin Yu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 7.  Use of nanoparticles in skeletal tissue regeneration and engineering.

Authors:  Miriam Filippi; Gordian Born; Delphine Felder-Flesch; Arnaud Scherberich
Journal:  Histol Histopathol       Date:  2019-11-13       Impact factor: 2.303

Review 8.  Nanoparticle-based monitoring of cell therapy.

Authors:  Chenjie Xu; Luye Mu; Isaac Roes; David Miranda-Nieves; Matthias Nahrendorf; James A Ankrum; Weian Zhao; Jeffrey M Karp
Journal:  Nanotechnology       Date:  2011-11-21       Impact factor: 3.874

9.  Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging.

Authors:  Fahd Azzabi; Markus Rottmar; Virginija Jovaisaite; Markus Rudin; Tullio Sulser; Andreas Boss; Daniel Eberli
Journal:  Tissue Eng Part C Methods       Date:  2014-08-04       Impact factor: 3.056

Review 10.  In vivo Cell Tracking Using Non-invasive Imaging of Iron Oxide-Based Particles with Particular Relevance for Stem Cell-Based Treatments of Neurological and Cardiac Disease.

Authors:  Markus Aswendt; Jean-Luc Boulland; Jasna Lojk; Stefan Stamenković; Joel C Glover; Pavle Andjus; Fabrizio Fiori; Mathias Hoehn; Dinko Mitrecic; Mojca Pavlin; Stefano Cavalli; Caterina Frati; Federico Quaini
Journal:  Mol Imaging Biol       Date:  2020-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.